KRAS mutant - Globe Thesis

Keyword [KRAS mutant] Result: 1 - 17 \| Page: 1 of 1
1.	A Novel Drug Combination Suppresses KRAS-mutant Cancers
2.	Characterization Of Macropinocytosis Structures Of Kras Mutant Pancreatic Cancer Cells And Internalization Of Mesoporous Silica Nanoparticles (MSNs) Into Pancreatic Cancer Cells As Anticancer Drug Delivery Devices
3.	Construction And Identification Of KRAS-mutant Cell Lines
4.	Simvastatin Resensitizes Cetuximab-resistant KRAS-mutant Human Colorectal Cancer Cells To Cetuximab
5.	A New Small Molecule Suppresses KRAS-mutant Cancers
6.	Multi-omics Integrative Analysis And In Silico Drug Screening In Subtypes Of KRAS-mutant Lung Adenocarcinoma
7.	Dual Inhibition Of VEGF And PARP Suppresses KRAS-mutant Colorectal Cancer
8.	Primary resistance to ATP-competitive mTOR inhibitors for the treatment of solid tumors
9.	Targeted Inhibition Of GLS1 Enhances The Antitumor Effect Of Selumetinib In KRAS-mutant Lung Adenocarcinoma And Its Molecular Imaging Evaluation
10.	The Function And Potential Therapeutic Value Of SDPR In KRAS-mutant Lung Cancer
11.	A Critical Role Of Arginine Specific Marylated GRP78/BiP Affacted By ART1 In The Progression Of KRAS Mutant Colorectal Cancer
12.	Study On SHP2 Expression And Its Predictive Significance In KRAS Mutant Non-small Cell Lung Cancer Treated With Immunotherapy
13.	The Effect And Mechanism Of ON123300 Combined With Chemotherapy On KRAS Mutant Colorectal Cancer Cell Line
14.	Exploration On Reversal Of Malignant Phenotype Of Pancreatic Cancer By Wild-type Kras Gene And Lnc-TNFAIP3 And Its Mechanism
15.	Inhibition Of ART1 To Induce M2 Macrophage Activation Assisted By Cetuximab In The Treatment Of KRAS Mutant Colorectal Cancer
16.	The Treatment Of KRAS Mutant Gastric Cancer And Its Mechanism By Dual-target Combination Therapy
17.	Profile Drug Metabolic Enzymes In KRAS Mutant Lung Cancer And Gender Differnences
<<First <Prev Next> Last>> Jump to